deCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Nat Commun. 2020 Jan 20;11(1):393. doi: 10.1038/s41467-019-14144-8.
Asthma is one of the most common chronic diseases affecting both children and adults. We report a genome-wide association meta-analysis of 69,189 cases and 702,199 controls from Iceland and UK biobank. We find 88 asthma risk variants at 56 loci, 19 previously unreported, and evaluate their effect on other asthma and allergic phenotypes. Of special interest are two low frequency variants associated with protection against asthma; a missense variant in TNFRSF8 and 3' UTR variant in TGFBR1. Functional studies show that the TNFRSF8 variant reduces TNFRSF8 expression both on cell surface and in soluble form, acting as loss of function. eQTL analysis suggests that the TGFBR1 variant acts through gain of function and together with an intronic variant in a downstream gene, SMAD3, points to defective TGFβR1 signaling as one of the biological perturbations increasing asthma risk. Our results increase the number of asthma variants and implicate genes with known role in T cell regulation, inflammation and airway remodeling in asthma pathogenesis.
哮喘是一种常见的慢性疾病,影响儿童和成人。我们报告了一项全基因组关联荟萃分析,该分析涉及来自冰岛和英国生物库的 69189 例病例和 702199 例对照。我们在 56 个位置发现了 88 个哮喘风险变异体,其中 19 个是以前未报道过的,并评估了它们对其他哮喘和过敏表型的影响。特别有趣的是两个与哮喘保护相关的低频变异体;TNFRSF8 中的错义变异体和 TGFBR1 中的 3'UTR 变异体。功能研究表明,TNFRSF8 变异体降低了细胞表面和可溶性形式的 TNFRSF8 表达,起功能丧失作用。eQTL 分析表明,TGFBR1 变异体通过获得功能起作用,并且与下游基因 SMAD3 中的内含子变异体一起,表明 TGFβR1 信号传导的缺陷是增加哮喘风险的生物学扰动之一。我们的结果增加了哮喘变异体的数量,并提示了已知在 T 细胞调节、炎症和气道重塑中起作用的基因在哮喘发病机制中的作用。